Immix Biopharma, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD for Q1 2022
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Immix Biopharma, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate for Q1 2022.
- Immix Biopharma, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2022 was $80.000.
- Immix Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $9.6K, a 522% increase from 2021.
- Immix Biopharma, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $1.54K, a 71.5% increase from 2020.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)